Cargando…
Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931839/ https://www.ncbi.nlm.nih.gov/pubmed/35234269 http://dx.doi.org/10.3892/or.2022.8297 |
| _version_ | 1784671348544503808 |
|---|---|
| author | Liu, Jia Dong, Bing-Fei Wang, Pei-Song Ren, Pei-You Xue, Shuai Zhang, Xiao-Nan Han, Zhe Chen, Guang |
| author_facet | Liu, Jia Dong, Bing-Fei Wang, Pei-Song Ren, Pei-You Xue, Shuai Zhang, Xiao-Nan Han, Zhe Chen, Guang |
| author_sort | Liu, Jia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8931839 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | D.A. Spandidos |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89318392022-03-25 Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo Liu, Jia Dong, Bing-Fei Wang, Pei-Song Ren, Pei-You Xue, Shuai Zhang, Xiao-Nan Han, Zhe Chen, Guang Oncol Rep Retraction D.A. Spandidos 2022-05 2022-03-01 /pmc/articles/PMC8931839/ /pubmed/35234269 http://dx.doi.org/10.3892/or.2022.8297 Text en Copyright: © Liu et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited. |
| spellingShingle | Retraction Liu, Jia Dong, Bing-Fei Wang, Pei-Song Ren, Pei-You Xue, Shuai Zhang, Xiao-Nan Han, Zhe Chen, Guang Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo |
| title | Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo |
| title_full | Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo |
| title_fullStr | Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo |
| title_full_unstemmed | Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo |
| title_short | Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo |
| title_sort | silencing nob1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo |
| topic | Retraction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931839/ https://www.ncbi.nlm.nih.gov/pubmed/35234269 http://dx.doi.org/10.3892/or.2022.8297 |
| work_keys_str_mv | AT liujia silencingnob1enhancesdoxorubicinantitumoractivityofthepapillarythyroidcarcinomainvitroandinvivo AT dongbingfei silencingnob1enhancesdoxorubicinantitumoractivityofthepapillarythyroidcarcinomainvitroandinvivo AT wangpeisong silencingnob1enhancesdoxorubicinantitumoractivityofthepapillarythyroidcarcinomainvitroandinvivo AT renpeiyou silencingnob1enhancesdoxorubicinantitumoractivityofthepapillarythyroidcarcinomainvitroandinvivo AT xueshuai silencingnob1enhancesdoxorubicinantitumoractivityofthepapillarythyroidcarcinomainvitroandinvivo AT zhangxiaonan silencingnob1enhancesdoxorubicinantitumoractivityofthepapillarythyroidcarcinomainvitroandinvivo AT hanzhe silencingnob1enhancesdoxorubicinantitumoractivityofthepapillarythyroidcarcinomainvitroandinvivo AT chenguang silencingnob1enhancesdoxorubicinantitumoractivityofthepapillarythyroidcarcinomainvitroandinvivo |